News & Updates

Show Multimedia Only

Novel RSV vaccine safe to use in solid organ transplant recipients

17 Nov 2025 by

Two doses of mRNA-1345 respiratory syncytial virus (RSV) vaccine 50 µg administered 56 days apart do not yield any safety concerns and are well-tolerated among solid organ transplant recipients (SOTRs), according to a study presented at IDWeek 2025.

Novel RSV vaccine safe to use in solid organ transplant recipients

17 Nov 2025

Novel mRNA-based vaccine prevents flu infection in adults

17 Nov 2025 by

The novel mRNA-based influenza vaccine mRNA-1010 has demonstrated superior efficacy over its standard-dose (SD) comparator in preventing RT-PCR–confirmed protocol-defined influenza disease in adults aged 50 years and above, reports a study presented at IDWeek 2025.

Novel mRNA-based vaccine prevents flu infection in adults

17 Nov 2025

Low-lying placenta a risk factor for postpartum bleeding

17 Nov 2025

Women with an antepartum diagnosis of low-lying placenta are twice as likely as those with normal placentation to have postpartum haemorrhage (PPH), according to a systematic review and meta-analysis.

Low-lying placenta a risk factor for postpartum bleeding

17 Nov 2025

Depot medroxyprogesterone acetate linked to increased meningioma risk

16 Nov 2025

Women using depot medroxyprogesterone acetate are at heightened risk of subsequent meningioma diagnosis, although the overall clinical risk is low, according to a retrospective study.

Depot medroxyprogesterone acetate linked to increased meningioma risk

16 Nov 2025

Major bleeding risk higher with ticagrelor vs clopidogrel in multiethnic ACS patients

16 Nov 2025 by

For multiethnic Southeast Asian patients with acute coronary syndrome (ACS), bleeding outcomes including BARC type 3 bleeding appear to be less favourable with ticagrelor than with clopidogrel, as shown in a retrospective study from Singapore.

Major bleeding risk higher with ticagrelor vs clopidogrel in multiethnic ACS patients

16 Nov 2025

Is DCB angioplasty better than stenting for de novo CAD?

16 Nov 2025

Drug-coated balloon (DCB) angioplasty with rescue stenting in patients with de novo coronary artery disease (CAD) results in a higher rate of device-oriented composite endpoint (DoCE) than intended drug-eluting stent (DES) implantation at 3 years, reports a study.

Is DCB angioplasty better than stenting for de novo CAD?

16 Nov 2025

Infection risk higher in adalimumab users with HS vs psoriasis

16 Nov 2025

Among adults receiving adalimumab treatment, those with hidradenitis suppurativa appear to be at greater risk of infection than their psoriasis counterparts, as reported in a retrospective study.

Infection risk higher in adalimumab users with HS vs psoriasis

16 Nov 2025

Large French study clears mRNA-based COVID-19 vaccines of teratogenic risk

15 Nov 2025 by

Receipt of messenger RNA (mRNA)-based COVID-19 vaccine during pregnancy does not appear to be associated with an increased risk of any major congenital malformations, according to new research from France.